Alzheimer's & Dementia · Sep 29, 2026
Tau-PET correlates of mild behavioral impairment in preclinical and prodromal Alzheimer's disease: A head-to-head comparison of Flortaucipir and MK6240
By Bizzi I, Macedo AC, Trudel L et al.
Introduction We compared the association between mild behavioral impairment (MBI) and first- versus second-generation tau-positron emission tomography (PET) tracers in preclinical and prodromal Alzheimer's disease (AD). Methods We assessed 110 individuals with head-to-head [ 18 F]MK6240 and [ 18 F]Flortaucipir tau-PET. Voxel-wise and region-of-interest analyses investigated relationships between tau-PET and MBI Checklist (MBI-C) scores, which were also compared across tau-PET positivity and PET-Braak stages. Results For both tracers, MBI severity was associated with tau-PET signal in all Braak regions and increased across PET-Braak stages. [ 18 F]MK6240 showed more extensive voxel-wise associations with MBI-C scores and additional correlations with affective symptoms in stratified analyses by diagnostic groups. Tau positivity was associated with a higher frequency of MBI. Individuals positive for [ 18 F]MK6240 but negative for [ 18 F]Flortaucipir exhibited greater MBI burden than individuals negative for both tracers. Discussion MBI in early AD is associated with tau-PET, with [ 18 F]MK6240 providing greater sensitivity to detect MBI-related symptoms.
doi.org/10.1002/alz.71861Open accessPubMed 42805926Biomarkers